alanine has been researched along with Fatty Liver in 13 studies
Alanine: A non-essential amino acid that occurs in high levels in its free state in plasma. It is produced from pyruvate by transamination. It is involved in sugar and acid metabolism, increases IMMUNITY, and provides energy for muscle tissue, BRAIN, and the CENTRAL NERVOUS SYSTEM.
alanine : An alpha-amino acid that consists of propionic acid bearing an amino substituent at position 2.
Fatty Liver: Lipid infiltration of the hepatic parenchymal cells resulting in a yellow-colored liver. The abnormal lipid accumulation is usually in the form of TRIGLYCERIDES, either as a single large droplet or multiple small droplets. Fatty liver is caused by an imbalance in the metabolism of FATTY ACIDS.
| Excerpt | Relevance | Reference |
|---|---|---|
| " In addition, increased hepatic microvasculatures compliance-related improved buffering effect of portal vein to acute mannitol infusion was associated with decreased circulating nitric oxide and aldosterone, plasma volume expansion (dye dilution method), splanchnic blood pooling ((99 m) Tc-RBC SPECT/PET/CT scans), peripheral hypotension, portal hypertension and ascites in brivanib and sorafenib-treated NASH-cirrhotic rats." | 3.80 | Anti-VEGFR agents ameliorate hepatic venous dysregulation/microcirculatory dysfunction, splanchnic venous pooling and ascites of NASH-cirrhotic rat. ( Hsieh, YC; Huang, YT; Lee, FY; Lee, KC; Lee, PC; Lee, WP; Lin, HC; Liu, RS; Tan, TW; Yang, YY; Yeh, YC, 2014) |
| "Rats were treated with a hepatotoxin thioacetamide (TAA) and examined 21 days later, when they showed moderate fatty metamorphosis of the liver and morphological changes in brain indicative of excitotoxic neuronal damage, but no evident biochemical or neurophysiological symptoms of hepatic encephalopathy (HE)." | 3.70 | Changes in the extracellular profiles of neuroactive amino acids in the rat striatum at the asymptomatic stage of hepatic failure. ( Albrecht, J; Borkowska, HD; Gadamski, R; Hilgier, W; Oja, SS; Saransaari, P; Walski, M; Zielińska, M, 1999) |
| "In all, 32 subjects (11 patients with nonalcoholic steatohepatitis [NASH], 15 with simple steatosis [SS], and six healthy controls) were studied." | 1.46 | Hepatic Alanine Differentiates Nonalcoholic Steatohepatitis From Simple Steatosis in Humans and Mice: A Proton MR Spectroscopy Study With Long Echo Time. ( Cho, EY; Choi, KH; Jeong, YY; Jun, CH; Jun, HY; Kim, KJ; Kim, TH; Lee, MS; Lee, YH; Yoon, KH; Yun, KJ, 2017) |
| "Histidine or carnosine treatments significantly improved insulin sensitivity and attenuated hyper-insulinemia (P<0." | 1.37 | Histidine and carnosine alleviated hepatic steatosis in mice consumed high saturated fat diet. ( Chao, CY; Mong, MC; Yin, MC, 2011) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 5 (38.46) | 18.7374 |
| 1990's | 1 (7.69) | 18.2507 |
| 2000's | 1 (7.69) | 29.6817 |
| 2010's | 5 (38.46) | 24.3611 |
| 2020's | 1 (7.69) | 2.80 |
| Authors | Studies |
|---|---|
| Bae, EJ | 1 |
| Choi, WG | 1 |
| Pagire, HS | 1 |
| Pagire, SH | 1 |
| Parameswaran, S | 1 |
| Choi, JH | 1 |
| Yoon, J | 1 |
| Choi, WI | 1 |
| Lee, JH | 1 |
| Song, JS | 1 |
| Bae, MA | 1 |
| Kim, M | 1 |
| Jeon, JH | 1 |
| Lee, IK | 1 |
| Kim, H | 1 |
| Ahn, JH | 1 |
| Schmilovitz-Weiss, H | 1 |
| Gingold-Belfer, R | 1 |
| Grossman, A | 1 |
| Issa, N | 1 |
| Boltin, D | 1 |
| Beloosesky, Y | 1 |
| Morag Koren, N | 1 |
| Meyerovitch, J | 1 |
| Weiss, A | 1 |
| Yang, YY | 1 |
| Liu, RS | 1 |
| Lee, PC | 1 |
| Yeh, YC | 1 |
| Huang, YT | 1 |
| Lee, WP | 1 |
| Lee, KC | 1 |
| Hsieh, YC | 1 |
| Lee, FY | 1 |
| Tan, TW | 1 |
| Lin, HC | 1 |
| Kim, TH | 1 |
| Jun, HY | 1 |
| Kim, KJ | 1 |
| Lee, YH | 1 |
| Lee, MS | 1 |
| Choi, KH | 1 |
| Yun, KJ | 1 |
| Jeong, YY | 1 |
| Jun, CH | 1 |
| Cho, EY | 1 |
| Yoon, KH | 1 |
| Peng, X | 1 |
| Zhang, L | 1 |
| Wang, Q | 1 |
| Cui, X | 1 |
| Rey, JW | 1 |
| Noetel, A | 1 |
| Hardt, A | 1 |
| Canbay, A | 1 |
| Alakus, H | 1 |
| Zur Hausen, A | 1 |
| Dienes, HP | 1 |
| Drebber, U | 1 |
| Odenthal, M | 1 |
| Mong, MC | 1 |
| Chao, CY | 1 |
| Yin, MC | 1 |
| Hilgier, W | 1 |
| Zielińska, M | 1 |
| Borkowska, HD | 1 |
| Gadamski, R | 1 |
| Walski, M | 1 |
| Oja, SS | 1 |
| Saransaari, P | 1 |
| Albrecht, J | 1 |
| Bannister, DW | 1 |
| Evans, AJ | 1 |
| Whitehead, CC | 1 |
| Whitehead, RG | 1 |
| Coward, WA | 1 |
| Lunn, PG | 1 |
| Henley, KS | 1 |
| Laughrey, EG | 1 |
| Clancy, PE | 1 |
| Sherwin, R | 1 |
| Joshi, P | 1 |
| Hendler, R | 1 |
| Felig, P | 1 |
| Conn, HO | 1 |
| Sandler, R | 1 |
| Freinkel, N | 1 |
13 other studies available for alanine and Fatty Liver
| Article | Year |
|---|---|
Peripheral Selective Oxadiazolylphenyl Alanine Derivatives as Tryptophan Hydroxylase 1 Inhibitors for Obesity and Fatty Liver Disease.
Topics: Adiposity; Alanine; Animals; Anti-Obesity Agents; Diet, High-Fat; Energy Metabolism; Enzyme Inhibito | 2021 |
Lowering the upper limit of serum alanine aminotransferase levels may reveal significant liver disease in the elderly.
Topics: Aged; Alanine; Alanine Transaminase; Aspartate Aminotransferases; Fatty Liver; Female; Fibrosis; Ger | 2019 |
Anti-VEGFR agents ameliorate hepatic venous dysregulation/microcirculatory dysfunction, splanchnic venous pooling and ascites of NASH-cirrhotic rat.
Topics: Alanine; Animals; Ascites; Cytokines; DNA Primers; Fatty Liver; Fibroblast Growth Factors; Microcirc | 2014 |
Hepatic Alanine Differentiates Nonalcoholic Steatohepatitis From Simple Steatosis in Humans and Mice: A Proton MR Spectroscopy Study With Long Echo Time.
Topics: Adult; Alanine; Animals; Area Under Curve; Biopsy; Case-Control Studies; Fatty Liver; Female; Hepato | 2017 |
[Study on the relationship between FABP2 Ala54Thr polymorphism and the risk of non-alcoholic fatty liver diseases].
Topics: Adult; Aged; Alanine; Amino Acid Substitution; Case-Control Studies; Fatty Acid-Binding Proteins; Fa | 2009 |
Pro12Ala polymorphism of the peroxisome proliferator-activated receptor γ2 in patients with fatty liver diseases.
Topics: Alanine; Biopsy; Fatty Liver; Humans; Polymorphism, Genetic; PPAR gamma; Proline | 2010 |
Histidine and carnosine alleviated hepatic steatosis in mice consumed high saturated fat diet.
Topics: Adipose Tissue; Alanine; Animals; Carnosine; Dietary Fats; Fatty Liver; Histidine; Insulin; Lipogene | 2011 |
Changes in the extracellular profiles of neuroactive amino acids in the rat striatum at the asymptomatic stage of hepatic failure.
Topics: Alanine; Amino Acids; Animals; Aspartic Acid; Biological Transport; Corpus Striatum; Excitatory Amin | 1999 |
Evidence for a lesion in carbohydrate metabolism in fatty liver and kidney syndrome in chicks.
Topics: Alanine; Animals; Biotin; Carbohydrate Metabolism; Chickens; Fatty Liver; Fructosephosphates; Glucon | 1975 |
Serum-albumin concentration and the onset of kwashiorkor.
Topics: Alanine; Child; Deficiency Diseases; Fatty Liver; Growth Hormone; Humans; Hydrocortisone; Insulin; K | 1973 |
Gluconeogenesis in the fatty liver of the rat: the effect of oleate and ethanol.
Topics: Acetoacetates; Alanine; Animals; Cytosol; Ethanol; Fatty Acids; Fatty Liver; Gluconeogenesis; Hydrox | 1973 |
Hyperglucagonemia in Laennec's cirrhosis. The role of portal-systemic shunting.
Topics: Adolescent; Adult; Aged; Alanine; Alcoholism; Amino Acids; Ammonia; Blood Glucose; Esophageal and Ga | 1974 |
Alcohol hypoglycemia. VI. Interrelationships between the formation of glyceride-glycerol and glucose from alanine by liver slices.
Topics: Alanine; Animals; Ethanol; Fatty Liver; Gluconeogenesis; Glycerides; Glycerol; Glycerophosphates; Hy | 1966 |